WRBC
CELUW icon

W.R. Berkley Corp’s Celularity Inc CELUW Stock Holding History

W.R. Berkley Corp’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27,732
Closed -$17K – 114
2019
Q3 		$17K Buy
+27,732
New +$15.9K ﹤0.01% 100

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

W.R. Berkley Corp's CELUW Position: Q4 2019 in Review

W.R. Berkley Corp sold out of Celularity Inc (CELUW) in Q4 2019, closing a stake of 27,732 shares — an estimated $17K sold.

W.R. Berkley Corp first reported a position in CELUW in Q3 2019 and held it in 1 quarter. The position peaked at $17K in Q3 2019. 22 funds tracked by Wall St. Rank hold CELUW as of Q4 2019.

  • W.R. Berkley Corp reported no remaining Celularity Inc position as of Q4 2019 after selling out during the quarter.
  • W.R. Berkley Corp sold 27,732 Celularity Inc shares in Q4 2019, an estimated $17K.
  • W.R. Berkley Corp first reported a position in Celularity Inc in Q3 2019 and held it in 1 quarter.
  • W.R. Berkley Corp's Celularity Inc position peaked at $17K in Q3 2019.
  • 22 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2019.

Based on W.R. Berkley Corp's 13F filing for Q4 2019, filed 14 Feb 2020.